Presenter: Robyn Kutka, ND

Original Date: April 13, 2019

It’s estimated that 25% of the world’s adult population has metabolic syndrome. This condition imposes significant health risks including a five-fold greater risk of type 2 diabetes and triple the risk of heart attack or stroke as compared to people without metabolic syndrome. Associated cardiovascular disease accounts for much of the financial burden associated with both metabolic syndrome and overt diabetes. Given these astounding numbers and global burden on health care budgets, it’s clear that earlier diagnosis and preventative approaches are needed.

Join us as we uncover diagnostic early indicators of metabolic syndrome and more overt disease processes including insulin resistance, diabetes and PCOS. Understand the pathophysiology and clinical presentations as the pertain to androgens and differ among the sexes. Review clinical cases from presentation through diagnosis and treatment, taking away clinical pearls ready to implement in your practice Monday Morning.

1.0 Pharmacology, 0.5 General (Total 1.5 CEUs) approved by OBNM